SIRT1 deacetylates SATB1 to facilitate MARHS2-MARε interaction and promote ε-globin expression by Xue, Zheng et al.
SIRT1 deacetylates SATB1 to facilitate MAR
HS2-
MAR
e interaction and promote e-globin expression
Zheng Xue
1, Xiang Lv
1, Wei Song
1, Xing Wang
1, Guang-Nian Zhao
1, Wen-Tian Wang
1,
Jian Xiong
1, Bei-Bei Mao
1, Wei Yu
1, Ben Yang
2, Jie Wu
1, Li-Quan Zhou
1, De-Long Hao
1,
Wen-Ji Dong
2, De-Pei Liu
1,* and Chih-Chuan Liang
1
1National Laboratory of Medical Molecular Biology and
2Department of Cell Biology, Institute of Basic
Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College,
Beijing 100005, P.R. China
Received May 5, 2011; Revised and Accepted January 18, 2012
ABSTRACT
The higher order chromatin structure has recently
been revealed as a critical new layer of gene tran-
scriptional control. Changes in higher order chroma-
tin structures were shown to correlate with the
availability of transcriptional factors and/or MAR
(matrix attachment region) binding proteins, which
tether genomic DNA to the nuclear matrix. How
posttranslational modification to these protein or-
ganizers mayaffect higher order chromatin structure
still pending experimental investigation. The type III
histone deacetylase silent mating type information
regulator 2, S. cerevisiae, homolog 1 (SIRT1) partici-
pates in many physiological processes through
targeting both histone and transcriptional factors.
We show that MAR binding protein SATB1, which
mediates chromatin looping in cytokine, MHC-I and
b-globin gene loci, as a new type of SIRT1 substrate.
SIRT1expressionincreasedaccompanyingerythroid
differentiation and the strengthening of b-globin
cluster higher order chromatin structure, while
knockdown of SIRT1 in erythroid k562 cells
weakened the long-range interaction between two
SATB1 binding sites in the b-globin locus, MAR
HS2
and MAR
". We also show that SIRT1 activity signifi-
cantly affects "-globin gene expression in a
SATB1-dependent manner and that knockdown of
SIRT1 largely blocks "-globin gene activation during
erythroid differentiation. Our work proposes that
SIRT1 orchestrates changes in higher order chroma-
tin structure during erythropoiesis, and reveals
the dynamic higher order chromatin structure regu-
lation at posttranslational modification level.
INTRODUCTION
Higher order chromatin structure plays an important role
in eukaryotic gene expression regulation. This regulation
permits selective cross talk between cis-regulatory
elements that are spaced far apart in the DNA sequence,
or even those present on separate chromosomes and there-
fore provides a transcription permissive or inhibitory en-
vironment for the RNA polymerase. Using Chromosome
Conformation Capture (3C) (1) and related high-
throughput technologies such as Hi-C (2), many function-
ally potent higher order chromatin structures have been
identiﬁed, including a/b-globin active chromatin hub (3,4)
and Igf-H19 imprinting structure (5,6). The nuclear matrix
ﬁbrous network within the cell nucleus acts as a scaf-
fold where matrix attachment region (MAR) elements
are anchored with the help of nuclear matrix binding
proteins. The selective and dynamic association of differ-
ent potential MARs to the nuclear matrix is closely related
to the expression of associated genes and gene clusters (7),
potentially through facilitated formation of the func-
tional chromatin higher order architecture. SATB1 is a
well-studied matrix binding protein that is actively
involved in the formation of the higher order chromatin
structure of cytokine gene cluster, MHC class I com-
pounds (8–10) and acts as a platform to recruit chromatin
remodeling complexes and histone modiﬁers (11). In
embryonic fetal stage K562 cells, SATB1 binds to
MARs located at hypersensitive site 2 (HS2) in the locus
control region and at the 50 regulatory region of the
e-globin gene. This binding activates e-globin gene expres-
sion through the recruitment of the cAMP Response
Element-Binding Protein (CREB) binding protein (CBP)
(12). Our previous work further showed that SATB1 re-
locates the b-globin gene cluster to the nuclear matrix and
mediates the formation of a long-range interaction among
the MARs (inter-MAR association); both these
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locus (13,14).
Posttranslational modiﬁcations of SATB1, including
phosphorylation and acetylation, have been reported to
modulate the trans-activity of SATB1 in T-cells (15,16).
PCAF (p300/CBP-associated factor) acetylates SATB1 at
lysine 136 and abolishes the ability of SATB1 to bind to
DNA, and PKC-mediated SATB1 phosphorylation
acts as a switch to determine the acetylation status
and transcriptional activity of SATB1 (15). In addition
to the above-mentioned SATB1 modulation at the
posttranslational level in T-cells, our previous work
showed that SATB1 acetylation decreased during hemin-
induced erythroid differentiation of K562 cells, whereas
no obvious protein abundance change was observed.
Also, SATB1 deacetylation was accompanied by the
strengthening of the ‘inter-MAR association’, which
implies the involvement of deacetylase in the modulation
of the higher order chromatin structure in the b-globin
gene locus (14).
silent mating type information regulator 2, S. cerevisiae,
homolog 1 (SIRT1) is a class III deacetylase that can
reverse acetylated substrates in a NAD
+ dependent
manner (17). As the closest homolog to the yeast Sir2 in
mammals, SIRT1 plays important roles in many physio-
logical processes, including aging (18), apoptosis (19), me-
tabolism (20) and differentiation (17). SIRT1 fulﬁlls these
functions by deacetylating its substrates, which include
FOXOs (18), p53 (19), PGC1-a (20) and Myo D (17).
The present understanding of the broad physiological
functions of SIRT1 indicates a potential role of the
deacetylase on the regulation of higher order chromatin
structure. In this study, we identify SATB1 as a substrate
of SIRT1. We show that SIRT1 promotes e-globin gene
expression by binding to the MAR elements of the
b-globin gene locus together with SATB1 and facilitating
the inter-MAR association between MAR
HS2 and MAR
e.
MATERIALS AND METHODS
Cell culture, retroviral infection and transfection
The 293A cells were maintained in a-MEM (GIBCO)
medium containing 10% fetal bovine serum (FBS). K562
cells were maintained in RPMI 1640 (GIBCO) containing
10% FBS. Retrovirus packaging 293T cells were main-
tained in DMEM (GIBCO) containing 10% FBS.
Umbilical cord blood (UCB) samples from normal
full-term deliveries were obtained with the approval
from the institutional and licensing committee and the
informed consent from all subjects. Human primary hem-
atopoietic cells were isolated using Anti-CD34-
Microbeads (MACS, Miltenyi Biotec) following separ-
ation of mononuclear cells from UCB samples by
density gradient centrifugation using a Percoll density
gradient (Amersham Pharmacia Biotech). The puriﬁed
human primary hematopoietic cells were cultured and
induced for erythroid differentiation using Epo as
described (21). 293T cells were transfected with recombin-
ant retrovirus vectors using Lipofectamine 2000 reagent
(Invitrogen). Media containing the retroviruses was
collected 48h later, ﬁltered and transferred onto target
cells with polybrene (1mg/ml) for 6h. Stable polyclonal
cell lines were selected by puromycin (1mg/ml) for 48h
after infection.
Coimmunoprecipitation, western blot analysis and
antibodies
Cells were lysed at 4 C for 30min in 1ml of modiﬁed
RIPA buffer containing 50mM Tris (pH 7.4), 150mM
NaCl, 1mM EDTA, 1% Nonidet P-40, 0.25%
Na-deoxycholate, 1mM PMSF and 1mg/ml each of
aprotinin, leupeptin and pepstatin. The lysates were
centrifuged at 13000rpm for 15min at 4 C to remove
the cellular debris. The cell lysates were precleared by
incubation at 4 C with control IgG and Protein A/G
agarose beads (Santa Cruz). After being centrifuged at
4 C and 2500rpm for 5min, the supernatant was
incubated with respective antibodies (anti-Myc antibody
from Santa Cruz, anti-SATB1 antibody from Abcam and
anti-SIRT1 antibody from Santa Cruz) and protein A/G
agarose beads overnight at 4 C. The immunocomplex was
washed with RIPA buffer ﬁve times, eluted by boiling in
SDS–PAGE buffer for 5min, and subjected to western
blot with the appropriate antibodies [anti-SATB1
antibody from Abcam and BD, anti-SIRT1 antibody
from Santa Cruz and Millipore, and anti-Acetylated
Lysine antibody (anti-K-Ac) from Cell Signaling
Technology].
Recombinant protein production, puriﬁcation and in vitro
acetylation/deacetylation analysis
GST-SATB1-1-204 and GST-PCAF were produced and
puriﬁed as described (22). Puriﬁed SIRT1 deacetylase,
NAD
+ and Ac-CoA were purchased from Sigma.
In vitro acetylation/deacetylation assays were performed
as described (18) with minor modiﬁcations. Brieﬂy, for
the in vitro acetylation assay, 5mg of GST-SATB1-1-204
was incubated with 1mg GST-PCAF in the presence of
acetyl-CoA (20mM) at 30 C for 1h. The reaction was per-
formed in a buffer solution containing 50mM Tris–HCl
(pH 8.0), 0.1mM EDTA, 1mM Dithiothreitol (DTT) and
10% glycerol. The products of the reaction were resolved
on a SDS–PAGE gel and analyzed by western blotting
with an anti-K-Ac antibody (Cell Signaling Technology)
or subjected to tandem mass spectrometry (MS/MS)
analysis using a 4700 Proteomics Analyzer (Applied
Biosystems). For the in vitro deacetylation assay,
Ac-GST-SATB1-1-204 was incubated in deacetylation
buffer containing 25mM Tris–HCl (pH 8.0), 137mM
NaCl, 2.7mM KCl, and 1mM MgCl2 and puriﬁed recom-
binant human SIRT1 (Sigma, 3.5U) in the presence or
absence of NAD (Sigma, 60mM) at 30 C for 1h. The
products of the reaction were resolved on a SDS–PAGE
gel and analyzed by western blotting with an anti-K-Ac
antibody (Cell Signaling Technology). The acetylated
peptides were synthesized at the Beijing Genomics
Institute and subjected to MS/MS after the in vitro
deacetylation reaction using a 4700 Proteomics Analyzer
(Applied Biosystems).
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The 293A cells were cotransfected with Myc-SATB1 and
pcDNA3.1 or pcDNA3.1-SIRT1. The cells were lysed and
immunoprecipitated with an anti-Myc antibody. The
immunocomplexes were resolved on SDS–PAGE and
analyzed by western blotting with an anti-K-Ac
antibody (Millipore). Acetylation of endogenous SATB1
in control and drug-challenged/genetic-modiﬁed K562
cells and in human HSC-derived primary erythroid cells
were detected by immunopreciptating the cell lysate with
anti-SATB1 antibody (Abcam). The immunocomplexes
were resolved on SDS–PAGE and analyzed by western
blotting with an anti-K-Ac antibody (Cell Signaling
Technology).
RNA isolation and analysis
Total RNA was isolated using Trizol (Invitrogen). For
real-time PCR analysis, cDNA was synthesized from
total RNA by M-MuLV reverse transcriptase (New
England Biolabs) with random primers (Takara). The
resulting cDNA was subjected to PCR analysis with
gene-speciﬁc primers using an IQ5 real-time PCR system
(BIO-RED). The housekeeping gene GAPDH was used as
the internal control. The PCR product was measured by
SYBR Green.
The primers used for real-time PCR were as follows:
e-globin forward primer: 50-CTTTGGAAACCTGTCGT
C-30
e-globin reverse primer: 50-CTTGCCAAAGTGAGTAG
C-30
g-globin forward primer: 50-GGCAACCTGTCCTCTGC
CTC-30
g-globin reverse primer: 50-GAAATGGATTGCCAAAA
CGG-30
SATB1 forward primer: 50-GATCTATGAATAAGCCT
TTGGAG-30
SATB1 reverse primer: 50-TTTCGTCCTGGTATATTC
GGT-30
GAPDH forward primer: 50-GGTCACCAGGGCTGCT
TTTA-30
GAPDH reverse primer: 50-GAGGGATCTCGCTCCTG
GA-30
Chromatin immunoprecipitation analysis
K562 cells were cross-linked in 1% formaldehyde for
15min before being resuspended in lysis buffer [1%
SDS, 10mM EDTA and 50mM Tris (pH 8.1)] containing
protease inhibitors cocktail (1mM PMSF and 1mg/ml
each of aprotinin, leupeptin and pepstatin). This
solution was sonicated on ice until the cross-linked chro-
matin DNA was sheared to an average length of 500bp.
The sonicated cell supernatant was diluted 10-fold in ChIP
dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2mM
EDTA, 16.7mM Tris–HCl (pH 8.1) and 167mM NaCl]
containing protease inhibitors cocktail. After incubation
with control IgG and protein A agarose, the precleared
chromatin was immunoprecipitated with an anti-SIRT1
antibody (Santa Cruz), an anti-SATB1 antibody
(Abcam), or pre-immune goat serum as the control at
4 C overnight. The precipitated complexes were recovered
by incubation with protein A-agarose at 4 C for 2h,
centrifuged at a low speed, and subjected to reverse
cross-linking. DNA within the complexes was extracted
with phenol–chloroform/isoamyl alcohol (25:24:1),
precipitated with ethanol and used for real-time PCR
analysis. For the quantiﬁcation of ChIP signals, Cycle
threshold (Ct) values were ﬁrst obtained for input, IgG
and ChIP samples from SYBR green-based real-time
PCR. Fold occupancy of ChIP signal and IgG control
with respect to input (1% of starting chromatin) was
calculated respectively with the equation: 2
CTinput-CTChIP
and 2
CTinput-CTIgG.
The primers used were as follows:
MAR-HS2-forward primer: 50-TGCCTCTACAAAAAG
TACAAAAATTAGC-30
MAR-HS2-reverse primer: 50-CCCCACAAGAGTCCA
AGTAAAAA-30
MAR-e-forward primer: 50-CACTGTCACCACCTTTA
AGGCA-30
MAR-e-reverse primer: 50-GTTGGCTCCTCATCTATC
TGCA-30
3C analysis
The 3C analysis was performed as previously described
(14). Brieﬂy, SIRT1 knockdown and control K562 cells
were subjected to 1.5% formaldehyde cross-linking for
15min. The cross-linked DNA was digested by a
HindIII restriction enzyme, intramolecularly ligated and
then reverse cross-linked. The ligation products were then
analyzed by real-time PCR for the spatial proximity
between the two fragments, each represented by one
primer. The primers used were as follows:
Ercc3-forward primer: 50-ACAGTAGTCAAGGCTGAG
GAA-30
Ercc3-reverse primer: 50-ATGGTGCTGAGTGAAAGA
AGT-30
MAR-HS2 primer: 50-TCTAATTTCTCGCATCCACAA
TAT-30
MAR-HS4 primer: 50-CCTGGGAACAGTTAAACAGC
AAC-30
MAR-e primer: 50-CACTAAGGGTGAGGATGC
TGAA-30
MAR-g primer: 50-AGCCTACAGCATACAGGGTTCA
T-30
RESULTS
SIRT1 interacts with SATB1
As SIRT1 physically interacts with its substrates, we ﬁrst
tested for interaction between SATB1 and SIRT1. SATB1
and SIRT1 cDNAs were subcloned into vectors with or
without a Myc tag. The Myc-tagged SATB1 and
non-tagged SIRT1, or Myc-tagged SIRT1 and non-tagged
SATB1, were then cotransfected into 293T cells and sub-
jected to a coimmunoprecipitation (coIP) assay. As shown
4806 Nucleic Acids Research, 2012,Vol.40, No. 11in Figure 1A and B, the exogenously expressed SIRT1 and
SATB1 coprecipitated reciprocally. A coIP assay of en-
dogenous SATB1 and SIRT1 in K562 cells further con-
ﬁrmed an interaction between these two proteins
(Figure 1C and D). Endogenous SIRT1 shows two
bands in the coIP assay, one at  80kDa and the other
at  110kDa. The SIRT1 protein immunoprecipitated by
SATB1 is dominated by the 80kDa moiety in the K562
cells (Figure 1D), although the 110 KD-SIRT1 moiety
also interacts with SATB1 (Figure 1C). Confocal micros-
copy analysis of the 293T cells cotransfected with
GFP-SATB1 and Cherry-SIRT1 revealed that SATB1
colocalized with SIRT1 (Figure 1E). These results demon-
strate that SIRT1 interacts with SATB1. Expression of
SIRT6 and SIRT7, the other two nuclear members of
the sirtuin family, were also detected in K562 cells, but
both of them show no interaction with SATB1 when
exogenously expressed in 293T cells (Supplementary
Figure S1).
SIRT1 deacetylates SATB1
We then tested whether SATB1’s acetylation status
changes in response to an inhibitor or activator of
SIRT1. 293 cells transfected with Myc-tagged SATB1
were treated with the class I and II histone deacetylase
inhibitor TSA (1mM), SIRT1 inhibitor Nicotinamide
(NAM) (5mM) or both for 10h. The cell lysates were
immunoprecipitated with an anti-Myc antibody, and
western blotting was performed with an antibody against
acetylated lysine. These analyses indicated that both TSA
and NAM increased SATB1 acetylation, and the effect of
NAM was greater than that of TSA (Figure 2A). To
detect whether SATB1 was directly deacetylated by
SIRT1, we performed an in vitro deacetylation assay. It
has been reported that SATB1 is acetylated at lysine 136
within its PSD95/Dlg-A/ZO-1 (PDZ)-like domain by
PCAF (15); therefore, we puriﬁed a truncated SATB1
protein containing amino acids 1–204 that covered the
Figure 1. SIRT1 interacts with SATB1. (A and B) 293 cells were transfected with the indicated protein-expressing vectors, lysed and immunopre-
cipitated (IP) with an anti-Myc monoclonal antibody, and western blotting was performed with the indicated antibodies. (C and D) K562 cells were
lysed, and endogenous proteins were IP with SATB1 or SIRT1 antibody before being probed with a SIRT1 or SATB1 antibody, respectively.
(E) SIRT1 colocalizes with SATB1. 293T cells were cotransfected with GFP-SATB1 and Cherry-SIRT1. Cells were photographed under a confocal
microscope. Two different microscopic ﬁelds were shown (UltraVIEW VoX 3D LCI system, PerkinElmer Life Sciences Inc., USA). Pearson’s
correlation coefﬁcients of GFP-SATB1 signal and Cherry-SIRT1 signal were shown beneath the panels.
Nucleic Acids Research, 2012,Vol.40, No. 11 4807Figure 2. SIRT1 deacetylates SATB1. (A) The 293 cells were transfected with Myc-SATB1 and then treated with TSA and NAM as indicated.
Immunoprecipitation was performed using a Myc antibody, and SATB1 acetylation levels were detected by western blotting with an acetylated-lysine
antibody. (B) In vitro acetylation assay. Truncated GST-SATB1-1-204 was acetylated in the presence of PCAF and Ac-CoA. The self-acetylated
PCAF was used as a positive control, and SATB1 acetylation was detected by western blotting with an acetylated-lysine antibody. The truncated
GST-SATB1-1-204 protein was detected by Ponceau S staining. (C) In vitro deacetylation assay. In vitro-acetylated GST-SATB1 1-204 was
deacetylated with SIRT1 and NAD
+. The self-acetylated PCAF was used as a positive control, and SATB1 acetylation was detected by western
blotting with an acetylated-lysine antibody. The truncated GST-SATB1-1-204 protein was detected by Ponceau S staining. (D) The 293 cells were
cotransfected with SIRT1 and Myc-SATB1-expressing vectors. Immunoprecipitation was then performed using a Myc antibody, and Myc-SATB1
acetylation levels were detected by western blotting with an acetylated-lysine antibody. The cell lysates were subjected to blotting with the indicated
antibodies to show the expression of exogenous SIRT1 and Myc-SATB1. (E) Amino acid sequence of SATB1 containing the acetylated K175.
(F) MS/MS spectrum analysis of the SATB1 peptide containing acetylated K136 before and after the in vitro deacetylation assay. (G) MS/MS
spectrum analysis of the SATB1 peptide containing acetylated K175 before and after the in vitro deacetylation assay.
4808 Nucleic Acids Research, 2012,Vol.40, No. 11PDZ-like domain and fusion expressed it with a GST tag.
GST-SATB1-1-204 was acetylated in vitro by PCAF in the
presence of acetyl-coenzyme A (acetyl-CoA). A western
blot using an antibody against acetylated lysine conﬁrmed
the efﬁcacy of the reaction (Figure 2B). Acetylated
GST-SATB-1-204 was used as a substrate for SIRT1 in
an in vitro deacetylation assay in the presence of the
coenzyme NAD
+ (Figure 2C). The auto-acetylated
PCAF, which is deacetylated by SIRT1 (23), served as a
positive control. We showed that SIRT1 deacetylates
GST-SATB1-1-204 in vitro. To determine whether
SIRT1 deacetylates SATB1 in vivo, we cotransfected 293
cells with Myc-tagged SATB1, a SIRT1 overexpression
construct or an empty vector and then immunopre-
cipitated the Myc-SATB1. By western blotting with an
acetylated-lysine antibody, we found that SIRT1
overexpression decreased the amount of detected
acetylated SATB1 (Figure 2D).
To further identify SIRT1 deacetylation sites on
SATB1, we ﬁrst detected acetylation sites on SATB1.
PCAF acetylated GST-SATB1-1-204 was subjected to
MS/MS. The analysis revealed that, besides the previously
reported lysine 136, the lysine 175 residue of SATB1 was
also acetylated by PCAF in vitro (Figure 2E). We then
synthesized two peptides containing either acetylated
lysine 136 or 175 as substrates and performed an in vitro
deacetylation assay in the presence of SIRT1 and NAD
+.
As shown in Figure 2F and G, MS/MS analysis
demonstrated that both lysines 136 and 175 of SATB1
are deacetylated by SIRT1 in vitro (See also the enlarged
MS/MS data in Supplementary Figure S2).
SIRT1 promotes e-globin gene expression
Given that SATB1 can activate the expression of the
e-globin gene in K562 cells (12–14), we hypothesized
that SIRT1, which interacts with and deacetylases
SATB1, could also inﬂuence e-globin gene expression.
K562 cells were treated with the SIRT1 activator
resveratrol for 24h or with the SIRT1 inhibitor NAM
for 10h. The expression of the e-globin gene was moni-
tored using real-time PCR. We found that resveratrol
activated e-globin gene expression in a concentration-
dependent manner (Figure 3A), whereas NAM decreased
the e-globin gene expression (Figure 3B), accompanied
with decreased SATB1 acetylation level upon resveratrol
challenge and increased SATB1 acetylation level after
NAM treatment (Figure 3A and B). We then determined
whether overexpression or knockdown of SIRT1 could
affect the mRNA abundance of the e-globin gene. In
agreement with the results obtained with resveratrol treat-
ment, SIRT1 overexpression in K562 cells promoted
e-globin gene expression dramatically (Figure 3C). In
contrast, the mRNA level of the e-globin gene decreased
signiﬁcantly in K562 cells with stable knockdown of
SIRT1 (Figure 3D), concomitant SATB1 acetylation
level was shown decreased upon SIRT1 overexpression
and increased in SIRT1-knockdown K562 cells
(Figure 3C and D).
Subsequently, we tested whether SIRT1 could also
promote the expression of the e-globin gene in human
primary erythroid cells. Human primary hematopoietic
stem cells (HSCs) were isolated from cord blood and
cultured in expansion medium for 1 week before being
stimulated by erythropoietin (Epo) for another 3–9 days
to induce erythroid differentiation. Similar to the K562
cells, treatment with resveratrol caused an upregulation
of e-globin gene expression, and treatment with NAM
caused a downregulation of e-globin gene expression in
human primary erythroid cells (Figure 3E and F). In
addition, human primary HSCs were infected with
retrovirus-interfering SIRT1 or luciferase, subjected to se-
lection with puromycin, and induced with Epo for 3 days.
We found that the SIRT1 interference also impaired
e-globin gene expression in these primary erythroid cells,
accompanied with increased SATB1 acetylation level
(Figure 3G).
To determine whether SATB1 is required for the
e-globin expression induced by SIRT1, we employed a
retrovirus-mediated gene transfer to establish stable
strains of K562 cells carrying mock, wild-type SATB1,
mutant SATB1 with a PDZ domain deletion (PDZ
SATB1), PDZ domain is the major partner-interacting
domain of SATB1 (24), or SATB1 with point mutations
at SIRT1 deacetylation sites (K136AK175A SATB1), the
latter two SATB1 plasmids lost both SIRT1 deacetylation
sites k136/k175, and are supposed to have impaired
response to SIRT1 activity. The cells were then treated
with a SIRT1 activator or inhibitor. As expected, the
PDZ-SATB1 exhibits very faint effect on the expression
of e-globin, consistent to a very weak activity of the con-
struct for the loss of PDZ domain (25,26). Real-time PCR
analysis further indicated that the expression of the
e-globin gene changed with the drug treatment in mock
and wild-type SATB1 overexpressing cell strains, whereas
the expression of the e-globin gene in PDZ SATB1 or
K136AK175A SATB1 overexpressing K562 cells showed
less or no response to resveratrol (Figure 4A and B) and
NAM (Figure 4C and D) treatments, indicating that the
acetylation sites in SATB1 provide a critical regulatory
domain that is required for the regulation of e-globin
gene expression by SIRT1.
SIRT1 is involved in the hemin-induced activation of
e-globin gene expression in K562 cells
The molecular mechanisms by which hemin induces
e-globin gene activation in K562 cells remain largely
unclear. We showed that SIRT1 deacetylates SATB1
and promotes e-globin gene expression, and we previously
observed that the acetylation of SATB1 decreases during
hemin-induced K562 cell erythroid differentiation (14),
suggesting that SIRT1 may participate in this process.
We detected SIRT1 expression with hemin-induced
K562 cell erythroid differentiation and found that
SIRT1 protein abundance increases with the extension
of hemin treatment (Figure 5A). We next determined
whether SIRT1 was recruited to the MAR elements of
the b-globin locus through its association with SATB1.
We performed chromatin immunoprecipitation (ChIP)
with a SIRT1 antibody in K562 cells before and after
hemin treatment. We then performed real-time PCR by
Nucleic Acids Research, 2012,Vol.40, No. 11 4809Figure 3. SIRT1 promotes e-globin gene expression in K562 and primary erythroid cells. (A and B) K562 cells were treated with resveratrol or
NAM, and e-globin mRNA levels were detected by real-time PCR. The accompany changes of SATB1 acetylation level were detected by western
blotting. Each error bar represents a standard deviation calculated from experiments performed in triplicate. Student’s t-test was used for statistical
analysis and P-values are indicated (**P<0.01, ***P<0.001). (C) K562 cells were transfected with pcDNA3.1 or pcDNA3.1-SIRT1. e-globin and
SIRT1 mRNA levels were detected by real-time PCR. Each error bar represents a standard deviation calculated from experiments performed in
triplicate. Student’s t-test was used for statistical analysis and P-value is indicated (**P<0.01). The SIRT1 protein levels and accompanying SATB1
acetylation levels were detected by western blot. (D) K562 cells were stably infected with a retrovirus carrying control shRNA or SIRT1 shRNA.
e-globin and SIRT1 mRNA levels in the stably infected cells were determined by real-time PCR. Each error bar represents a standard deviation
calculated from experiments performed in triplicate. Student’s t-test was used for statistical analysis and P-value is indicated (**P<0.01). The SIRT1
protein levels and accompanying SATB1 acetylation levels were determined by western blotting. (E and F) HSCs were selected from cord blood,
cultured in medium for 1 week, and treated with Epo for 3 days to induce erythroid differentiation. The primary erythroid cells were then treated
with resveratrol or NAM, and e-globin mRNA levels were determined by real-time PCR. Each error bar represents a standard deviation calculated
from experiments performed in triplicate. Student’s t-test was used for statistical analysis and P-value is indicated (*P<0.05, **P<0.01). (G) The
selected HSCs were infected with a retrovirus carrying control shRNA or SIRT1 shRNA. Polyclones were selected by puromycin before being
subjected to Epo induction for 3 days. e-globin and SIRT1 mRNA levels were detected by real-time PCR. The accompany change of SATB1
acetylation level was detected by western blotting. Each error bar represents a standard deviation calculated from experiments performed in triplicate.
Student’s t-test was used for statistical analysis and P-value is indicated (*P<0.05).
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HS2 and MAR
e, where SATB1
binding has been previously identiﬁed (14). Our results
conﬁrmed the binding of SIRT1 to these two MARs in
uninduced K562 cells, and the binding increased after the
hemin induction of the K562 cells (Figure 5B and C). Very
weak re-ChIP signals of SATB1 and SIRT1 at both
MARs were detected in hemin-induced K562 cells,
implying that SIRT1 can bind to the MARs in complex
with SATB1 (Supplementary Figure S5). These observa-
tions suggest that SIRT1 may participate in the
hemin-induced activation of e-globin gene expression in
K562 cells. To further test this hypothesis, we treated
SIRT1 downregulated K562 cells and control cells with
increased amounts of hemin for 2 days. Real-time PCR
showed that e-globin gene expression increased with
increasing amounts of hemin in control K562 cells,
whereas the mRNA level of the e-globin gene was much
lower in the SIRT1 down-regulated K562 cells than in
control cells, and the induction of e-globin in response
to hemin was signiﬁcantly impaired (Figure 5D). These
results altogether indicate that SIRT1 plays an important
role in the hemin-induced activation of e-globin gene
expression in K562 cells. Furthermore, we detected
SIRT1 expression during Epo-induced erythroid differen-
tiation of umbilical HSCs. SIRT1 mRNA abundance
ﬂuctuated but increased overall during erythroid differen-
tiation, concomitant decrease in SATB1 acetylation level
was also detected (Figure 5E).
SIRT1 increases the binding of SATB1 to the MARs and
facilitates the formation of the inter-MAR association in
the b-globin gene locus
To further investigate the molecular mechanisms of
SIRT1’s regulatory function on e-globin gene expression
through SATB1, the ChIP assay was applied to detect
SATB1’s binding to MAR
HS2 and MAR
e in control and
SIRT1-interfered K562 cells. Both semi-quantitative and
real-time PCR showed that SATB1’s binding to MAR
HS2
and MAR
e decreased in SIRT1-interfered K562 cells
(Figure 6A and B), the observation agrees with a
previous report that acetylated-SATB1 binds DNA less
efﬁciently (15).
Our previous work demonstrated that SATB1 mediates
the long-distance interaction between MAR
HS2 and
MAR
e and that this higher order chromosome organiza-
tion contributes to the transcriptional activity of the
Figure 4. SATB1 is essential for the regulatory function of SIRT1 in e-globin gene expression in K562 cells. (A and B) K562 cells were stably
infected with a retrovirus carrying a control vector, wild-type SATB1, SATB1 with a PDZ-like domain deletion or SATB1 with point mutations at
deacetylation sites (K136AK175A SATB1). Polyclones were selected by puromycin and then treated with resveratrol (50mM if unspeciﬁed). e-Globin
mRNA levels were determined by real-time PCR. Each error bar represents a standard deviation calculated from experiments performed in triplicate.
Student’s t-test was used for statistical analysis and P-value is indicated (*P<0.05, **P<0.01). (C and D) K562 cells were stably infected with a
retrovirus carrying a control vector, wild-type SATB1, SATB1 with a PDZ-like domain deletion or SATB1 with point mutations at deacetylation
sites (K136AK175A SATB1). Polyclones were selected by puromycin and then treated with NAM (5mM). e-Globin mRNA levels were determined
by real-time PCR. Each error bar represents a standard deviation calculated from experiments performed in triplicate. Student’s t-test was used for
statistical analysis and P-value is indicated (*P<0.05, **P<0.01).
Nucleic Acids Research, 2012,Vol.40, No. 11 4811e-globin gene (14). Thus, we examined the association
between MAR
HS2 and MAR
e in control and SIRT1
knockdown K562 cells. A 3C assay with HindIII frag-
ments of the b-globin gene cluster indicated that the asso-
ciation between MAR
HS2 and MAR
e decreased upon
SIRT1 knockdown (Figure 6C).
DISCUSSION
This study establishes the MAR binding protein SATB1
as a new substrate of the class III deacetylase SIRT1 and
supports that SIRT1 participates in e-globin gene activa-
tion during erythroid differentiation. Moreover, we
provide evidence that SIRT1 exerts its regulatory effect
on e-globin gene expression by enhancing SATB1’s
binding to MAR
HS2 and MAR
e and strengthening the
association between the two MARs. These results
suggest that SIRT1 is a regulator of the higher order chro-
matin structure.
SIRT1 interacts with and deacetylates SATB1
SATB1 is a well-deﬁned chromatin organizer that is
involved in the expression regulation of multiple gene
clusters (27). SATB1 recruits subunits of the
nucleosome-mobilizing complexes CHRAC and ACF
and the NURD chromatin remodeling complex, including
histone deacetylases HDAC1 and HDAC2 (11). Using ex-
ogenous and endogenous co-IP assays and ﬂuorescent
cellular colocalization analysis, we found that the class
III histone deacetylase SIRT1 also binds to SATB1 in
both the 293 and the erythroid K562 cell lines and
deacetylates SATB1.
The PDZ-like domain is adjacent to the N-terminal
end of SATB1 and is mainly responsible for the
homodimerization and protein partner association of
SATB1 (25). In addition, PDZ-like domain mediated di-
merization is required for the high-afﬁnity DNA binding
of SATB1 (26). This domain also includes the previously
reported PCAF acetylation site lysine 136 and PKC
Figure 5. SIRT1 promotes e-globin gene expression during hemin-induced K562 cell erythroid differentiation. (A) Hemin induction of K562 cells
increases SIRT1 protein expression. K562 cells were treated with hemin. The cells were harvested at different time periods and then subjected to
western blotting using a SIRT1 antibody. (B and C) Hemin increases SIRT1 binding to the MARs of the b-globin gene cluster. K562 cells were
treated with hemin for 24h. The ChIP assay was performed with an anti-SIRT1 antibody to detect the binding of SIRT1 to MAR
HS2 and MAR
e
before and after hemin induction. Each error bar represents a standard deviation calculated from experiments performed in triplicate. Student’s t-test
was used for statistical analysis and P-value is indicated (*P<0.05, **P<0.01). (D) SIRT1 interference impaired the hemin-induced activation of the
e-globin gene in K562 cells. Stable control shRNA and SIRT1 shRNA K562 cells were treated with increased concentration of hemin (0, 10, 25 and
50mM) for 24h, and e-globin mRNA levels were detected by real-time PCR. Each error bar represents a standard deviation calculated from
experiments performed in triplicate. Student’s t-test was used for statistical analysis and P-value is indicated (**P<0.01, ***P<0.001).
(E) HSCs were selected from cord blood, and treated with Epo to induce erythroid differentiation. The cells were harvested at different time
periods and SIRT1 mRNA levels were determined by real-time PCR. SATB1 acetylation levels before and after 6d Epo induction were detected
by western blotting. Each error bar represents a standard deviation calculated from experiments performed in triplicate. Student’s t-test was used for
statistical analysis and P-value is indicated (**P<0.01).
4812 Nucleic Acids Research, 2012,Vol.40, No. 11phosphorylation site serine 185 (15). Therefore, we
focused on this PDZ domain in our further screening of
the SIRT1 deacetylation sites on SATB1. In addition to
lysine 136, we found lysine 175 as a new PCAF acetylation
site on SATB1; we also found that SIRT1 could
deacetylate SATB1 at both sites in vitro.
SIRT1 is a new regulator of e-globin gene expression
SATB1 is a known activator of the e-globin gene (12);
therefore, we detected the effect of SIRT1 on e-globin
gene expression. The drug challenges and genetic modiﬁ-
cations of SIRT1 expression in the erythroid K562 cell line
and human primary erythroid cells conﬁrmed the positive
linkage between SIRT1 and e-globin gene expression. The
activity of SIRT1 also extends to other globin genes, as we
found that SIRT1 also increased the expression of the
g-globin gene (Supplementary Figure S3). Although no
SIRT1 substrate, except SATB1, is known to participate
in globin gene regulation, we cross-checked whether the
regulatory effect of SIRT1 on e-globin gene expression
depended on SATB1 acetylation. K562 cells that ex-
pressed mutant SATB1 proteins that lack the SIRT1 tar-
geting sites (K136 and K175) became insensitive to
treatment with a SIRT1 activator (resveratrol) and an in-
hibitor (NAM), which have a strong impact on e-globin
expression in normal K562 cells. A mild positive effect of
SIRT1 on SATB1 expression was also observed
(Supplementary Figure S4), which could synergize with
the SATB1 deacetylation effect of SIRT1 in regulating
e-globin gene expression.
Our observation that both protein abundance of SIRT1
and its recruitment to the SATB1 speciﬁc MAR
HS2 and
MAR
e increased during hemin induction of K562 cells
suggests the involvement of SIRT1 in K562 erythroid dif-
ferentiation. This is further supported by the analysis
showing that SIRT1 interference greatly impaired
hemin-induced e-globin gene activation in K562 cells.
Moreover, our observation of primary erythroid cells
revealed a ﬂuctuating increase of SIRT1 and concomitant
decrease in SATB1 acetylation during erythroid differen-
tiation in umbilical HSCs. We also found that resveratrol,
the activator of SIRT1, stimulates the e-globin gene ex-
pression in the primary erythroid cells, whereas the SIRT1
inhibitor, NAM, and direct SIRT1 knockdown in these
primary cells inhibited the e-globin gene expression.
Collectively, these results suggest an active role of
SIRT1 in the physiological process of e-globin gene acti-
vation during erythropoiesis.
SIRT1 regulates the inter-MAR association of the
b-globin gene cluster via posttranslational modiﬁcation
of SATB1
Recent studies have identiﬁed multiple SIRT1 substrates
with various physiological roles, including P53 (19),
FOXO (18), PGC1-a (20) and HIF-2a (28). SIRT1 func-
tions by deacetylating these factors and regulating their
transcriptional activities, protein stability or cellular local-
ization. In addition to acting on transcriptional factors,
SIRT1 also participates in heterochromatin organization
by interacting with DNA methyltransferase 3b (29) or by
deacetylating histone H1 (30) and SUV39H1 (31,32), a
histone methyl transferase. However, there are no
reports concerning the involvement of SIRT1 in the regu-
lation of long-range higher order chromatin structure.
Our previous work identiﬁed an association between
MAR
HS2, MAR
HS4, MAR
e and MAR
g in the b-globin
gene cluster, and we showed that SATB1 mediates this
inter-MAR association (14). SATB1, presumably as part
of a macro–protein complex, coordinately mediates the
formation of the inter-MAR association in the b-globin
gene cluster, and the polymerization characteristic of the
SATB1 protein makes it the potential core element in
organizing the inter-MAR association. Modiﬁcations to
the components of the protein complex may accordingly
affect the formation of the inter-MAR association and the
globin gene expression.
In this study, we found that SIRT1 deacetylates SATB1,
facilitates the inter-MAR association between MAR
HS2
and MAR
e and promotes e-globin gene expression. This
work establishes the linkage between SIRT1 and higher
Figure 6. SIRT1 facilitates the formation of the inter-MAR associ-
ation. (A and B) Knockdown of SIRT1 by RNA interference decreases
SATB1 binding to the MARs of the b-globin gene cluster. Stable
control shRNA and SIRT1 shRNA K562 cells were subjected to
ChIP assay with an anti-SATB1 antibody. The coprecipitated chroma-
tin DNA was analyzed by semi-quantitative PCR and real-time PCR
using primers that amplify MAR
HS2 and MAR
e. Each error bar rep-
resents a standard deviation calculated from experiments performed in
triplicate. Student’s t-test was used for statistical analysis and P-values
are indicated (**P<0.01). (C) Knockdown of SIRT1 by RNA inter-
ference decreases the inter-MAR association in the b-globin gene
cluster. Stable control shRNA and SIRT1 shRNA K562 cells were
subjected to the 3C assay with HindIII digestion. The spatial proximity
between MAR
HS2 and MAR
e was analyzed using real-time PCR. Each
error bar represents a standard deviation calculated from experiments
performed in triplicate. Student’s t-test was used for statistical analysis
and P-value is indicated (*P<0.05).
Nucleic Acids Research, 2012,Vol.40, No. 11 4813order chromatin structure regulation. It also provides an
important example of how posttranslational modiﬁcations
on protein components affect the organization of
long-range higher order chromatin structure and ﬁne regu-
lation of targeted gene expression. Other posttranslational
modiﬁcations of SATB1, including phosphorylation (15)
and sumoylation (33), may also participate in the regula-
tion of the inter-MAR association. Further investigations
on the posttranslational modiﬁcations to these higher
order chromatin structure organizers are still needed to
comprehensively understand the dynamic transcriptional
regulation at the 3D chromatin organization level.
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